In conclusion, this case describes the significant clinical, diagnostic and therapeutic differences between STAT5B-RARα t(17;17) and PML-RARα t(15;17) fusion-positive APL and highlights the role of molecular diagnostics, cytogenetics and flow cytometry in the identification of this rare APL variant. Here, RARA is linked to acute promyelocytic leukemia.